These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11030490)
1. Is antipsychotic drug--induced weight gain associated with a favorable clinical response? Lamberti JS J Clin Psychiatry; 2000 Sep; 61(9):678. PubMed ID: 11030490 [No Abstract] [Full Text] [Related]
2. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317 [TBL] [Abstract][Full Text] [Related]
3. Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics? Sharma E; Rao NP; Venkatasubramanian G; Behere RV; Varambally S; Sivakumar PT; Gangadhar BN Psychiatry Res; 2011 Mar; 186(1):155. PubMed ID: 20691482 [No Abstract] [Full Text] [Related]
4. A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia. Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty TK; Gangadhar BN Clin Neuropharmacol; 2010; 33(6):288-92. PubMed ID: 21060283 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study. Chen YQ; Li XR; Zhang L; Zhu WB; Wu YQ; Guan XN; Xiu MH; Zhang XY J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004092 [TBL] [Abstract][Full Text] [Related]
6. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [TBL] [Abstract][Full Text] [Related]
7. Weight gain among schizophrenic patients treated with clozapine. Lamberti JS; Bellnier T; Schwarzkopf SB Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460 [TBL] [Abstract][Full Text] [Related]
9. Eating-behavior changes associated with antipsychotic medications in patients with schizophrenia as measured by the drug-related eating behavior questionnaire. Ryu S; Nam HJ; Oh S; Park T; Lim M; Choi JS; Baek JH; Jang JH; Park HY; Kim SN; Joo YH; Kwon JS; Hong KS J Clin Psychopharmacol; 2013 Feb; 33(1):120-2. PubMed ID: 23277254 [No Abstract] [Full Text] [Related]
10. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Strassnig M; Miewald J; Keshavan M; Ganguli R Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082 [TBL] [Abstract][Full Text] [Related]
11. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421 [TBL] [Abstract][Full Text] [Related]
12. Bofu-tsusho-san effectively attenuates the weight gain observed after receiving olanzapine. Yamamoto N; Inada T Psychiatry Clin Neurosci; 2008 Dec; 62(6):747. PubMed ID: 19068015 [No Abstract] [Full Text] [Related]
13. Outcome in males with first-episode schizophrenia: 7-year follow-up. Ceskova E; Prikryl R; Kasparek T World J Biol Psychiatry; 2011 Feb; 12(1):66-72. PubMed ID: 21087079 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole for the management of olanzapine-induced weight gain. Englisch S; Weinbrenner A; Inta D; Zink M Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397 [No Abstract] [Full Text] [Related]
15. Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Poyurovsky M; Isaacs I; Fuchs C; Schneidman M; Faragian S; Weizman R; Weizman A Am J Psychiatry; 2003 Feb; 160(2):297-302. PubMed ID: 12562576 [TBL] [Abstract][Full Text] [Related]
16. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study. Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823 [TBL] [Abstract][Full Text] [Related]
17. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059 [TBL] [Abstract][Full Text] [Related]
18. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia. Simpson GM; Weiden P; Pigott T; Murray S; Siu CO; Romano SJ Am J Psychiatry; 2005 Aug; 162(8):1535-8. PubMed ID: 16055779 [TBL] [Abstract][Full Text] [Related]
20. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate. Lin YH; Liu CY; Hsiao MC Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]